Literature DB >> 29949199

Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.

Chunlong Li1, Panpan Guo2, Akinkunmi Paul Okekunle2, Xiaoning Ji2, Min Huang2, Jiayue Qi2, Yongshuai Jiang3, Rennan Feng2, Rui Li4.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease that involves a complex interaction between genetics, diet, and lifestyle. Although closely related with obese subjects, it is also common in lean humans. This study aimed to characterize the diet and lifestyle of lean and obese NAFLD patients in China.
METHODS: To characterize the diet and lifestyle of lean and obese NAFLD patients, we conducted a matched case-control study that included 351 Chinese adults. General characteristics, dietary intake, and lifestyle were gathered by using a valid and reliable dietary questionnaire. We compared the dietary intake and lifestyle between lean and obese NAFLD patients.
RESULTS: All NAFLD patients had more total caloric, calorigenic nutrients (carbohydrate, fat, and protein), grain, potato, fruit, and iron with higher levels of waist circumference and overtime work but shorter sleep duration than their corresponding controls. Particularly, lean NAFLD patients consumed comparable total caloric, calorigenic nutrients, iron, sleep duration, and overtime work as obese NAFLD patients, though they consumed lower levels of grain, potato, and fruit (lean NAFLD patients vs. obese NAFLD patients: mean ± SD, g/day grain: 291.8 ± 83.8, 365.2 ± 89.0; potato: 63.5 ± 33.1, 80.4 ± 37.6; fruit: 324.3 ± 148.4, 414.0 ± 220.4; P < 0.0001).
CONCLUSION: Non-alcoholic fatty liver disease patients had higher total caloric, calorigenic nutrients, grain, potato, fruit, iron, and overtime work but shorter sleep duration. Lean NAFLD patients had comparable total caloric, calorigenic nutrients, iron, sleep duration, and overtime work as obese NAFLD patients. These features could be used to the nutritional education and therapeutic guidance for lean NAFLD patients in the future.
© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  NAFLD; diet; lean; lifestyle; obese

Mesh:

Substances:

Year:  2018        PMID: 29949199     DOI: 10.1111/jgh.14360

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?

Authors:  Takumi Kawaguchi; Takuji Torimura
Journal:  J Gastroenterol       Date:  2019-11-28       Impact factor: 7.527

2.  Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease.

Authors:  Mi Na Kim; Kyungdo Han; Juhwan Yoo; Yeonjung Ha; Young Eun Chon; Ju Ho Lee; Tracey G Simon; Andrew T Chan; Seong Gyu Hwang
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

Review 3.  Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD.

Authors:  Sílvia Vilarinho; Veeral Ajmera; Melanie Zheng; Rohit Loomba
Journal:  Hepatology       Date:  2021-10       Impact factor: 17.298

Review 4.  Non-alcoholic fatty liver disease in lean individuals.

Authors:  Somaya Albhaisi; Abhijit Chowdhury; Arun J Sanyal
Journal:  JHEP Rep       Date:  2019-08-30

5.  Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.

Authors:  Lampros Chrysavgis; Eleftheria Ztriva; Adonis Protopapas; Konstantinos Tziomalos; Evangelos Cholongitas
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

6.  Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.

Authors:  Lin Guan; Xinhe Zhang; Haoyu Tian; Xing Jin; Hang Fan; Ningning Wang; Jing Sun; Dan Li; Jia Li; Xue Wang; Zilu Zeng; Yiling Li
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692

Review 7.  Lean NAFLD: an underrecognized and challenging disorder in medicine.

Authors:  Sheila Maier; Amanda Wieland; Melanie Cree-Green; Kristen Nadeau; Shelby Sullivan; Miguel A Lanaspa; Richard J Johnson; Thomas Jensen
Journal:  Rev Endocr Metab Disord       Date:  2021-01-03       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.